FDA QMSR: what changes when Part 820 is harmonized with ISO 13485
Standard & Framework · Medical Device Software
The QMSR incorporates ISO 13485:2016 into 21 CFR Part 820 by reference from February 2, 2026, so each design history file entry built under §820.30 is re-mapped to the 10 subclauses of ISO 13485 §7.3, not rebuilt.
The Quality System Regulation Amendments finalize a harmonization, not a replacement: 21 CFR Part 820's design-controls substance (§820.30(a)-(j) — design input, output, review, verification, validation, transfer, and changes) survives, now incorporated by reference through ISO 13485:2016 rather than restated as its own free-standing U.S. text.
What QMSR actually changed
Medical Devices; Quality System Regulation Amendments, 89 FR 7496 (Docket No. FDA-2021-N-0507), incorporates ISO 13485:2016 by reference into 21 CFR Part 820, with a compliance date of February 2, 2026. This is a harmonization of two previously separate quality-system regimes (the U.S. QSR and the international ISO 13485 standard most other regulators already required), not a new set of substantive design-control obligations — the design-controls content device makers already had to satisfy under §820.30 maps onto ISO 13485:2016 clauses covering the same activities.
Design controls: same substance, one fewer parallel document set
| Pre-QMSR (21 CFR §820.30) | Post-QMSR (ISO 13485:2016 reference) |
|---|---|
| §820.30(a) — General | Design and development planning |
| §820.30(c) — Design input | Design and development inputs |
| §820.30(d) — Design output | Design and development outputs |
| §820.30(e) — Design review | Design and development review |
| §820.30(f) — Design verification | Design and development verification |
| §820.30(g) — Design validation | Design and development validation |
| §820.30(h) — Design transfer | Design and development transfer outputs |
| §820.30(i) — Design changes | Control of design and development changes |
| §820.30(j) — Design history file | Design and development files |
What doesn't change: the traceability an auditor actually checks
Whichever clause numbering a MedTech device maker's quality manual cites under the QMSR, the evidence an FDA investigator or notified-body auditor actually pulls is the same: a design history file that traces every input to a verified, validated output, with each design review and change recorded as a design history file entry — the same chain an Architecture Decision Record is built to carry for the software-specific design decisions inside that file.
Engineering reference only. Not formal regulatory counsel. Consult your own quality system and legal counsel for a specific regulatory determination, particularly around your organization's own QMSR transition timeline.
Provenance & review state
- Last reviewed
- Sources
-
- 21 CFR Part 820 — U.S. Food and Drug Administration
- FDA Final Rule, Medical Devices; Quality System Regulation Amendments, 89 FR 7496 (Docket No. FDA-2021-N-0507) — U.S. Food and Drug Administration
- Ingested from
-